Detailed price information for Coca-Cola Company (KO-N) from The Globe and Mail including charting and trades.
Colgate-Palmolive reported Q3 2026 sales of US$5,369 million and net income of US$751 million, with both basic and diluted EPS from continuing operations at US$0.94. The company also raised full year 2026 guidance to 4% to 5% net sales growth, with higher gross margin expectations. The combination of higher quarterly revenue and earnings per share, alongside an outlook that now points to margin expansion, indicates that Colgate-Palmolive is relying on pricing, mix and cost efficiency rather...
Investors are piling into dependable dividend stocks following the midterm elections. But after their latest rallies, are these three Dividend Kings still worth buying?
Colgate-Palmolive is a Dividend King that investors shouldn't wait to embrace.
Colgate-Palmolive is rated Buy, supported by strong execution, margin expansion, and a valuation below its historical average. Learn more on CL stock here.
The fair value estimate for Colgate-Palmolive has moved from US$98.80 to US$101.70, which points to a modestly higher price target range in the latest analysis. This change lines up with recent Street commentary that responds to the Q3 2026 earnings beat and updated guidance, with both bullish and cautious views feeding into where analysts now set their targets. As you read on, you will see how this evolving narrative around Colgate-Palmolive can shape your own ongoing tracking of the...
Colgate-Palmolive now guides full-year 2026 organic sales growth to be broadly in line with the first three quarters. Read why CL stock is a hold.
Motley Fool Press Release.
Colgate-Palmolive (CL) raised its full-year earnings growth outlook on Friday as the consumer produc
This is the newest page. Registered accounts read further back.